Kara Gay, PA
Physician Assistant · Charleston, SCNPI 1528608510
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 690 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 690 payments — averaging $18.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$991
- Otsuka America Pharmaceutical, Inc.$968
- Vanda Pharmaceuticals Inc.$859
- Axsome Therapeutics, Inc.$813
- plus $6K from 29 others
What the payments were for
- Food & beverage$12,73199%
- Education$741%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 175 | $2,438 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 56 | $1,207 |
| Alkermes, Inc. | 53 | $991 |
| Otsuka America Pharmaceutical, Inc. | 54 | $968 |
| Vanda Pharmaceuticals Inc. | 36 | $859 |
| Axsome Therapeutics, Inc. | 35 | $813 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $734 |
| Lundbeck LLC | 41 | $727 |
| Sunovion Pharmaceuticals Inc. | 32 | $682 |
| Johnson & Johnson | 28 | $585 |
| Supernus Pharmaceuticals, Inc. | 11 | $339 |
| Neurocrine Biosciences, Inc. | 13 | $307 |
| Corium, LLC | 13 | $291 |
| Bausch Health US, LLC | 11 | $238 |
| Neos Therapeutics, LP | 20 | $221 |
| Indivior Inc. | 11 | $217 |
| Harmony Biosciences LLC | 11 | $210 |
| Tris Pharma Inc | 7 | $151 |
| Idorsia Pharmaceuticals US Inc | 7 | $130 |
| E.r. Squibb & Sons, L.L.C. | 5 | $91 |
| Teva Pharmaceuticals USA, Inc. | 6 | $89 |
| Noven Therapeutics, LLC | 4 | $78 |
| Pfizer | 3 | $65 |
| Almatica Pharma LLC | 4 | $57 |
| Eisai Inc. | 4 | $50 |
| Avanir Pharmaceuticals, Inc. | 3 | $48 |
| Jazz Pharmaceuticals Inc. | 2 | $48 |
| Merck | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| Braeburn Inc. | 2 | $28 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Alfasigma USA, Inc. | 1 | $12 |
| Hikma Pharmaceuticals USA | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$107
How this compares
$12,805 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 39 | $1,194 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 24 | $835 |
| Doxepin Hcl | 13 | $590 |
| Gabapentin | 65 | $494 |
| Sertraline Hcl | 14 | $442 |
| Quetiapine Fumarate | 34 | $430 |
| Fluoxetine Hcl | 68 | $361 |
| Mirtazapine | 20 | $356 |
| Lamotrigine | 33 | $345 |
| Clonazepam | 42 | $326 |
| Divalproex Sodium ErDivalproex Sodium | 11 | $267 |
| Prazosin Hcl | 12 | $222 |
| Zolpidem Tartrate | 20 | $161 |
| Diazepam | 13 | $88 |
| Trazodone Hcl | 35 | $85 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $57 | $44214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Charleston
- Michael OvercashCharleston$210K
- Elizabeth HardingCharleston$28K
- Whitney PutillionCharleston$18K
- Corin JaynesCharleston$17K
- Karen ByrdCharleston$16K
- Colleen ManningCharleston$14K
- John RicheyCharleston$12K
- John HendrickCharleston$11K
- Keenan RosadoCharleston$10K
- Ashley MackintoshCharleston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.